Zepbound shortage update: FDA issues limited availability warning. When might it end?

Get the Full StoryAccording to the FDA, affected doses of Eli Lilly s popular weight loss drug are expected to see limited availability until the end of April.

In response to a surge in demand, Zepbound, the weight loss drug manufactured by Eli Lilly, is facing a shortage of certain doses in the United States, as highlighted in a recent warning issued by the Food and Drug Administration FDA .

Share: